Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Psychedelic stocks are trading so low right now that there is no better time to invest, according to one venture capital firm. Investors have been given...
Psychedelics startups want to transform mental healthcare. But first, they need to win over the skeptics and break the taboos.
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said its wholly-owned subsidiary Cedar Clinical Research (CCR) has begun studying COMP360 psilocybin therapy, an...
Shares of Compass Pathways PLC climbed on Friday after the U.S.-listed healthcare group announced a successful follow-up study of a psychedelic drug used to…
As the psychedelic medicine gold rush accelerates, there are ways to game the system and some companies are testing the limits of patent law.